Drug Trial News

RSS

Study provides further insight into the molecular control of apoptosis

Researchers at Yale School of Medicine have gained deeper understanding of two members of a family of proteins called caspases that play a key role in promoting apoptosis, a process in which the cell responds to external signals by essentially committing suicide.

23 Feb 2006

Low bone density improved with jabs twice a year

A team of researchers say that women with low bone density can benefit from a twice a year treatment of an experimental drug.

23 Feb 2006

Glucosamine/Chondroitin combo helps those with moderate to severe joint pain

According to a new study by the National Institutes of Health, people with moderate to severe joint discomfort found that a combination of glucosamine and chondroitin resulted in significant pain and function improvement.

23 Feb 2006

Cell growth and cell division genes identified

A recent study shows that hundreds of genes contribute to cell growth and cell division. For the first time these genes, many of which are potential contributors to cancer, have been mapped in a single systematic study.

23 Feb 2006

Selective T cell stimulation could help improve treatment of autoimmune disease and cancer

The findings could also be significant for developing new ways to help patients with autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, or juvenile diabetes.

23 Feb 2006

We may learn best on an empty stomach!

Researchers at Yale School of Medicine have found evidence that a hormone produced in the stomach directly stimulates the higher brain functions of spatial learning and memory development.

23 Feb 2006

Singulair pill shows more promise for obese people

As the nation's collective waistline has swelled in recent decades, rates of asthma diagnoses also have accelerated. Indeed, much research has affirmed a link between the two conditions.

23 Feb 2006

40 percent of Americans at moderate risk for heart disease

"Nearly half the heart attacks come without warning, which means we need to do a better job of screening people. This test has that potential."

23 Feb 2006

New oral vaccine against Pseudomonas aeruginosa

A new oral vaccine against Pseudomonas aeruginosa, a bacterium commonly known for afflicting patients with lung dysfunction, has shown to protect healthy human volunteers from infection say researchers from England and Australia.

23 Feb 2006

Discovery of mechanisms responsible for the difference in immune response between male and female mice

The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.

23 Feb 2006

Avastin trial for pancreatic tumors

"Our findings from the previous study suggest that the combination of chemotherapy and radiation is a safe and effective treatment method to reduce the local extent of pancreatic tumors," said Dr. Talamonti.

23 Feb 2006

External counterpulsation not effective as a treatment for heart failure

A new review of studies supports the government's opinion that too little evidence exists to support a device that uses balloon-like pants as a treatment for heart failure.

23 Feb 2006

Surname prediction from DNA alone may be feasible

By comparing the DNA of 150 pairs of men who share British surnames, researchers have shown that about a quarter of pairs are linked genetically.

23 Feb 2006

Six-year study on teenage sexual behaviour

Teen girls reported they were twice as likely to engage in sexual intercourse in the evenings as after school, according to research by Indiana University School of Medicine researchers.

23 Feb 2006

Heart health and lifestyle help seniors maintain brain power

A comprehensive review says heart health risk factors and lifestyle choices, such as exercise, learning new things and staying socially connected, help keep brains healthy as we grow old.

22 Feb 2006

Statins and beta blockers may reduce heart attack risk

For patients with undiagnosed heart disease, taking a statin or beta blocker could mean the difference between experiencing mild chest pain, or having a full-blown heart attack as a first symptom. That's the finding of a Kaiser Permanente study in the February 21 issue of the Annals of Internal Medicine.

21 Feb 2006

Ebola DNA vaccine shows promise

Vical Incorporated has announced that an Ebola vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated, and produced both antibody and T-cell Ebola-specific responses in all healthy volunteers who received the full 3 doses of vaccine.

21 Feb 2006